title: Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variables.
abstract: An assay was standardized to measure extrinsic pathway inhibitor (EPI) activity in human plasma. Variables that could potentially influence its measurement were systematically examined. The coefficient of variation of the assay was 6.3% for the same sample assayed on different days. The linear regression line for a plot of observed v expected values of mixtures of plasmas with different EPI levels was Y = 1.01X - 2.7%. Single samples from 21 healthy adults under 60 years of age varied between 74% and 159% of a pooled reference plasma. The plasma level of a given individual (eight subjects) did not vary on repeat sampling over weeks to months. EPI activity was significantly lower in plasma from umbilical cord blood (64.3% +/- 12.7%, n = 16) than in plasma from adults. Mean EPI activity in adults greater than or equal to 60 years of age was slightly but significantly higher (112% +/- 16.8%, n = 23) than in adults less than 60 years of age (97.2% +/- 19.0%, n = 21). EPI levels in the third trimester of pregnancy were slightly higher than in nonpregnant women. Plasma EPI levels fell slightly after surgical procedures that caused fibrinogen levels to rise, which suggests that EPI is not an acute phase reactant. Administration of 1-desamino-8-d-arginine vasopressin (DDAVP) did not alter plasma EPI levels. In two patients subjected to plasmapheresis and volume replacement with albumin and isotonic saline, plasma EPI levels returned to one-half of the levels before pheresis within about one day.
authors: Department of Medicine, University of California, San Diego, La Jolla.
authors: T A
authors: TA
authors: Warr
authors: B J
authors: BJ
authors: Warn-Cramer
authors: L V
authors: LV
authors: Rao
authors: S I
authors: SI
authors: Rapaport
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis; D000328:Adult; D000367:Age Factors; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D005167:Factor VII / Q000037:antagonists & inhibitors*; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D006801:Humans; D007700:Kinetics; D008074:Lipoproteins; D009363:Neoplasm Proteins / Q000032:analysis* / Q000502:physiology; D010956:Plasmapheresis; D011247:Pregnancy / Q000097:blood; D011480:Protease Inhibitors / Q000032:analysis* / Q000502:physiology; D013925:Thromboplastin / Q000037:antagonists & inhibitors*; D013997:Time Factors
chemical_list: D000209:Acute-Phase Proteins; D008074:Lipoproteins; D009363:Neoplasm Proteins; D011480:Protease Inhibitors; C051928:lipoprotein-associated coagulation inhibitor; D005167:Factor VII; D013925:Thromboplastin; D003894:Deamino Arginine Vasopressin